Hims & Hers and Tempus AI are transforming digital health in distinct ways, but which platform looks more compelling right ...

Hims & Hers Health, Inc. (HIMS) closed at $28.89 in the latest trading session, marking a -5.19% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 1.16% for the ...

What Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 2.2% in the morning session after Morgan ...

Hims & Hers is down 30% but still a Buy: margin expansion, GLP-1 clarity, new hormone care, and global growth. Learn more about HIMS stock here.

Hims & Hers Health (HIMS) is back in focus as investors reassess its telehealth model, weighing GLP-1 related interest and ...

Hims & Hers Health, Inc. faces short-term pressure after missing Novo’s partner list, but lab testing boosts long-term growth ...

Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term losses lately. The San Francisco, CA-based ...

Detailed price information for American Well Corp Cl A (AMWL-N) from The Globe and Mail including charting and trades.

Hims & Hers is disrupting the healthcare industry, testing the limits of regulation to make it easier for people to buy popular drugs at lower prices online. This week, the telehealth company faced ...

Add Yahoo as a preferred source to see more of our stories on Google. The New York Stock Exchange with a Hims & Hers Health, Inc banner is pictured as a person runs past in the Manhattan borough of ...